Vancomycin-resistant Staphylococcus aureus (VRSA) infection is a serious bacterial infection caused by specific Staphylococcus aureus strains that cannot be treated with the antibiotic vancomycin. It primarily affects hospitalized patients, those with chronic health conditions, or individuals with indwelling medical devices.
We're working with Apple to restore our app. Use our Web App or Android app below.
*Staphylococcus aureus* resistance to vancomycin was first reported in 2002, following years of increasing vancomycin use. This emergence marked a significant and concerning development in the global fight against antimicrobial resistance, as vancomycin was considered a last-resort antibiotic for MRSA. Its appearance highlighted the urgent need for new antimicrobial agents and stronger infection control practices.
VRSA primarily spreads through direct contact with an infected person's wounds, bodily fluids, or contaminated skin. It can also spread indirectly via contact with contaminated surfaces, objects, or medical equipment. Transmission is most common in healthcare settings where patients may have open wounds, medical devices, or weakened immune systems.
Contagious Period: Varies by disease
Real-time intelligence from global health monitoring and AI-powered surveillance
Data sources: BEACON, ProMED, WHO, CDC, and 50+ national health agencies
Our AI-powered surveillance hasn't detected significant Vancomycin resistant Staphylococcus aureus infection activity in the past 30 days.
Real-time monitoring continues 24/7 across BEACON, ProMED, WHO, CDC, and 50+ global health agencies
Currently, Vancomycin resistant Staphylococcus aureus infection case counts are within baseline expectations globally. However, diseases can emerge rapidly, which is why continuous monitoring is critical.
Download the Virus Watcher app to get instant alerts if Vancomycin resistant Staphylococcus aureus infection activity increases in your region or travel destinations.
Even without active outbreaks, understanding Vancomycin resistant Staphylococcus aureus infection prevention helps protect you and your community:
Track Vancomycin resistant Staphylococcus aureus infection and 200+ other diseases with personalized alerts
Trusted information from leading health organizations
Official guidance from the U.S. Centers for Disease Control and Prevention
View CDC Resources โGlobal disease surveillance and guidelines from the World Health Organization
View WHO Resources โDisease information on Virus Watcher is reviewed by our Chief Epidemiologist, a former CDC lead analyst for FluSight forecasting. Outbreak data is aggregated from verified sources including BEACON, ProMED, WHO, CDC, and 50+ national health agencies. This information is for educational purposes and should not replace professional medical advice.
Last reviewed: 2026-06-19
Get real-time alerts and intelligence on Vancomycin resistant Staphylococcus aureus infection and 200+ other diseases. Used by healthcare systems, EMS, schools, and travelers worldwide.
We're working with Apple to restore our app. Use our Web App or Android app below.